Administration of Subcutaneous IL-2 is Associated with Strong Induction of Regulatory T Cells in High-Risk Neuroblastoma Patients Treated with Dinutuximab Beta, A SIOPEN Study
PEDIATRIC BLOOD & CANCER(2019)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要